We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+3.54%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$90.3B
AUM Growth
+$7.19B
(+8.7%)
Cap. Flow
+$4.56B
Cap. Flow
% of AUM
5.05%
Top 10 Holdings %
Top 10 Hldgs %
12.91%
Holding
4,527
New
567
Increased
2,145
Reduced
1,207
Closed
344
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$526M |
| 2 |
US Bancorp
USB
|
+$301M |
| 3 |
Pultegroup
PHM
|
+$217M |
| 4 |
BATS
Bats Global Markets, Inc.
BATS
|
+$145M |
| 5 |
Charter Communications
CHTR
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARG
Airgas Inc
ARG
|
+$477M |
| 2 |
Pfizer
PFE
|
+$305M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$294M |
| 4 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$275M |
| 5 |
XIV
VelocityShares Daily Inverse VIX Short Term ETN
XIV
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.61% |
| 2 | Technology | 10.97% |
| 3 | Healthcare | 10.51% |
| 4 | Consumer Discretionary | 7.19% |
| 5 | Industrials | 6.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Acadia Healthcare
ACHC
$2.76B
| $3.17M | ﹤0.01% |
57,119
-10,445
| -15% | -$611K |
|
1902
John Wiley & Sons Class A
WLY
$2.65B
| $3.17M | ﹤0.01% |
60,641
+23,754
| +64% | +$1.2M |
|
1903
HDFC Bank
HDB
$123B
| $3.16M | ﹤0.01% |
190,728
+11,200
| +6% | +$179K |
|
1904
Nuveen Credit Strategies Income Fund
JQC
$704M
| $3.16M | ﹤0.01% |
391,081
+128,349
| +49% | +$1.02M |
|
1905
Dine Brands
DIN
$456M
| $3.16M | ﹤0.01% |
37,215
+22,656
| +156% | +$1.94M |
|
1906
Wendy's
WEN
$1.4B
| $3.15M | ﹤0.01% |
327,772
+31,281
| +11% | +$328K |
|
1907
BWX Technologies
BWXT
$15.5B
| $3.15M | ﹤0.01% |
88,080
+13,487
| +18% | +$462K |
|
|
CLNY
1908
DELISTED
Colony Capital, Inc.
CLNY
| $3.15M | ﹤0.01% |
205,218
-45,171
| -18% | -$785K |
|
1909
Bright Horizons
BFAM
$3.92B
| $3.15M | ﹤0.01% |
47,488
+16,199
| +52% | +$1.05M |
|
|
MGLN
1910
DELISTED
Magellan Health Services, Inc.
MGLN
| $3.15M | ﹤0.01% |
47,825
+7,149
| +18% | +$481K |
|
1911
Dana Inc
DAN
$2.9B
| $3.14M | ﹤0.01% |
297,770
+43,169
| +17% | +$533K |
|
1912
Ryanair
RYAAY
$30.4B
| $3.14M | ﹤0.01% |
112,795
-42,215
| -27% | -$1.37M |
|
1913
Brady Corp
BRC
$4.44B
| $3.13M | ﹤0.01% |
102,318
+36,587
| +56% | +$1.06M |
|
1914
iShares US Oil Equipment & Services ETF
IEZ
$361M
| $3.13M | ﹤0.01% |
+80,988
| New | +$3.04M |
|
1915
Rollins
ROL
$18.3B
| $3.12M | ﹤0.01% |
240,026
-68,663
| -22% | -$842K |
|
|
AGN
1916
CALL
DELISTED
Allergan plc
AGN
| $3.12M | ﹤0.01% |
+13,500
| New | +$3.11M |
|
|
IPXL
1917
DELISTED
Impax Laboratories, Inc.
IPXL
| $3.12M | ﹤0.01% |
108,237
+55,811
| +106% | +$1.82M |
|
|
MRC
1918
DELISTED
MRC Global
MRC
| $3.12M | ﹤0.01% |
219,170
-162,335
| -43% | -$2.25M |
|
|
EFII
1919
DELISTED
Electronics for Imaging
EFII
| $3.12M | ﹤0.01% |
72,401
+9,898
| +16% | +$417K |
|
1920
Itron
ITRI
$4.36B
| $3.11M | ﹤0.01% |
72,208
-10,388
| -13% | -$438K |
|
1921
AMN Healthcare
AMN
$1.3B
| $3.08M | ﹤0.01% |
77,013
+27,424
| +55% | +$1.01M |
|
1922
PUT
Western Digital
WDC
$188B
| $3.07M | ﹤0.01% |
+85,995
| New | +$2.83M |
|
|
FINL
1923
DELISTED
Finish Line
FINL
| $3.06M | ﹤0.01% |
151,496
+31,150
| +26% | +$589K |
|
|
COHR
1924
DELISTED
Coherent Inc
COHR
| $3.04M | ﹤0.01% |
33,103
-7,800
| -19% | -$719K |
|
1925
VanEck Pharmaceutical ETF
PPH
$959M
| $3.03M | ﹤0.01% |
51,722
+20,284
| +65% | +$1.18M |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2016 Portfolio in Review
As of Q2 2016, Credit Suisse held 4,527 positions worth $90.3B, up 8.7% from $83.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Credit Suisse deployed $4.56B of net new capital in Q2 2016, opening 567 new positions and adding to 2,145 existing holdings. Its largest new stake was Bats Global Markets, Inc.: 5,676,642 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $305M trimmed.
- Credit Suisse's largest Q2 2016 buy was Bats Global Markets, Inc.: 5,676,642 shares worth $146M.
- Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $526M increase.
- Credit Suisse's biggest Q2 2016 reduction was Pfizer, cutting an estimated $305M.
- Credit Suisse fully exited Airgas Inc in Q2 2016, selling an estimated $477M.
- Credit Suisse's ten largest holdings make up 13% of its $90.3B portfolio in Q2 2016.
- Credit Suisse opened 567 new positions and closed 344 in Q2 2016.
- Credit Suisse's portfolio value rose 8.7% quarter-over-quarter to $90.3B.
Based on Credit Suisse's 13F filing for Q2 2016, filed 11 Aug 2016.